These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 33335961)

  • 41. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
    Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
    Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.
    Vasen HF; Watson P; Mecklin JP; Lynch HT
    Gastroenterology; 1999 Jun; 116(6):1453-6. PubMed ID: 10348829
    [No Abstract]   [Full Text] [Related]  

  • 43. Recent advances in Lynch syndrome.
    Li X; Liu G; Wu W
    Exp Hematol Oncol; 2021 Jun; 10(1):37. PubMed ID: 34118983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modifier genes and Lynch syndrome: some considerations.
    Scott RJ
    Hered Cancer Clin Pract; 2022 Sep; 20(1):35. PubMed ID: 36088367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-exome sequencing identified a novel mutation of
    Ghaedi H; Ramsheh SM; Omidvar ME; Labbaf A; Alehabib E; Akbari S; Pourfatemi F; Darvish H
    Genes Dis; 2020 Dec; 7(4):614-619. PubMed ID: 33335961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
    Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
    Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review: Clinical aspects of hereditary DNA Mismatch repair gene mutations.
    Sijmons RH; Hofstra RMW
    DNA Repair (Amst); 2016 Feb; 38():155-162. PubMed ID: 26746812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.